About us
The Androgens in Health and Disease research group at RCSI encompasses both translational research and clinical expertise with a focus on polycystic ovary syndrome, congenital adrenal hyperplasia, endocrine-related cancers and metabolic disease.
Latest news
![]()
NEW REVIEW: 11-Oxy Androgens in Human Health
A new review co-authored by Clinical Lead, Prof Michael O'Reilly alongside prominent biochemist, Prof Karl-Heinz Storbeck (Stellenbosch University,…
![]()
Research seminar series April 2023
Team member Stephanie Agabana MSc, will be presenting her research into androgens in endocrine resistant breast cancers at…
![]()
Development of a novel 3D bioprinting model to explore skeletal muscle energy metabolism in women with PCOS
Funding has been awarded to Dr McIlroy and Prof O'Reilly to develop a 3D bioprinting model to explore…
Our team
We are a collaborative team of clinical and translational researchers with a specific interest in sex steroids in health and disease with a specific focus on androgens in women's health.
Professor Michael O’Reilly – Clinical Group Lead
Honorary Clinical Associate Professor, RCSI and Consultant Endocrinologist, Beaumont Hospital
Principal Investigator
Dr Marie McIlroy – Scientific Group Lead
Senior Lecturer & Principal Investigator, Department of Surgery, RCSI Scientific Lead for the Endocrine-Related Cancer Programme, Beaumont RCSI Cancer Centre. Dublin.
Principal Investigator
Dr Leanne Cussen
ICAT Fellow and PhD Scholar
Co-Investigator
Dr Tara McDonnell
Clinical Research Fellow and PhD Scholar
Co-Investigator
Dr Clare Miller
StAR MD - RCSI
Co-Investigator
Stephanie Agbana MSc
PhD Scholar, RCSI (2022-2026)
Co-Investigator
Zahra Farahbakhsh MSc
Research Assistant
Co-Investigator
Professor Wiebke Arlt
William Withering Chair of Medicine Director of the Institute of Metabolism and Systems Research University of Birmingham
Collaborator
